GNS Healthcare leads a precision strike on investor wallets, securing $23 million in new financing for its "precision" medicine software that supposedly gets the right treatment to the right patient.
Pretentiously named Change Healthcare went public, raising around $750 million. The firm offers IT systems for health care providers and data and analytic services.
Inbox Health, which, oooohhh, claims to be both a digital health and a fintech company, isn't that incredible, raises a not so incredible $4.4 million financing round for its communication platform to help providers with patient billing.
Disease management vendor Omada Health has secured yet another large round of financing, $73 million worth. Lot of hype around the new generation of disease management vendors, but I predict the same outcome in terms of value to patients and payers and returns to investors--not much.
Spring Fertility plows fertile investing ground, getting an undisclosed amount of new capital to help people become pregnant. Gestation period for this investment was undisclosed but likely will be greater than nine months.
Cara Care, a German digital health company focused on digestive system care (if its digital does that mean stick a finger in one or the other end of your alimentary canal?) gets a $7 million financing round that includes pharma giant J & J.
Collective Health has raised a massive $205 million round of new capital, as it grows its third-party administrator business for employee health benefit plans.
Large insurer Centene has led a $60 million investment in Quartet, which offers a comprehensive technology platform to coordinate and deliver behavioral health care.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.